185 related articles for article (PubMed ID: 1901416)
1. Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.
Lee MK; Lander AD
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2768-72. PubMed ID: 1901416
[TBL] [Abstract][Full Text] [Related]
2. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding.
Herndon ME; Stipp CS; Lander AD
Glycobiology; 1999 Feb; 9(2):143-55. PubMed ID: 9949192
[TBL] [Abstract][Full Text] [Related]
3. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin.
San Antonio JD; Slover J; Lawler J; Karnovsky MJ; Lander AD
Biochemistry; 1993 May; 32(18):4746-55. PubMed ID: 8490019
[TBL] [Abstract][Full Text] [Related]
4. The structure of glycosaminoglycans and their interactions with proteins.
Gandhi NS; Mancera RL
Chem Biol Drug Des; 2008 Dec; 72(6):455-82. PubMed ID: 19090915
[TBL] [Abstract][Full Text] [Related]
5. Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides.
Ogamo A; Nagai A; Nagasawa K
Biochim Biophys Acta; 1985 Jul; 841(1):30-41. PubMed ID: 2861857
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.
Huynh MB; Ouidja MO; Chantepie S; Carpentier G; Maïza A; Zhang G; Vilares J; Raisman-Vozari R; Papy-Garcia D
PLoS One; 2019; 14(1):e0209573. PubMed ID: 30608949
[TBL] [Abstract][Full Text] [Related]
8. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
Hallak LK; Collins PL; Knudson W; Peeples ME
Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
[TBL] [Abstract][Full Text] [Related]
9. Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans.
Talaga ML; Fan N; Fueri AL; Brown RK; Bandyopadhyay P; Dam TK
Biochemistry; 2016 Aug; 55(32):4541-51. PubMed ID: 27427828
[TBL] [Abstract][Full Text] [Related]
10. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
[TBL] [Abstract][Full Text] [Related]
11. A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies.
Takada W; Fukushima M; Pothacharoen P; Kongtawelert P; Sugahara K
Anal Biochem; 2013 Apr; 435(2):123-30. PubMed ID: 23333222
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycans that bind cold-insoluble globulin in cell-substratum adhesion sites of murine fibroblasts.
Laterra J; Ansbacher R; Culp LA
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6662-6. PubMed ID: 6256752
[TBL] [Abstract][Full Text] [Related]
13. Interactions between fibronectin and chondroitin sulfate are modulated by molecular context.
Barkalow FJ; Schwarzbauer JE
J Biol Chem; 1994 Feb; 269(6):3957-62. PubMed ID: 8307950
[TBL] [Abstract][Full Text] [Related]
14. Binding properties of glycosaminoglycans to lysozyme--effect of salt and molecular weight.
Van Damme MP; Moss JM; Murphy WH; Preston BN
Arch Biochem Biophys; 1994 Apr; 310(1):16-24. PubMed ID: 8161200
[TBL] [Abstract][Full Text] [Related]
15. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
16. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
17. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
Alberdi E; Hyde CC; Becerra SP
Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
[TBL] [Abstract][Full Text] [Related]
18. Predicting glycosaminoglycan surface protein interactions and implications for studying axonal growth.
Griffith AR; Rogers CJ; Miller GM; Abrol R; Hsieh-Wilson LC; Goddard WA
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13697-13702. PubMed ID: 29229841
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of proteoglycan-mimetic graft copolymers with tunable glycosaminoglycan density.
Place LW; Kelly SM; Kipper MJ
Biomacromolecules; 2014 Oct; 15(10):3772-80. PubMed ID: 25171516
[TBL] [Abstract][Full Text] [Related]
20. The interaction of platelet factor four and glycosaminoglycans.
Loscalzo J; Melnick B; Handin RI
Arch Biochem Biophys; 1985 Jul; 240(1):446-55. PubMed ID: 2409923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
